TRPV1 and chronic rhinosinusitis with nasal polyps: Hence, TRPV1 is implicated in all aspects of the pathophysiological mechanisms underlying AR and CRSwNP and leading to nasal symptoms, rendering it a worthy candidate for pharmacological modulation.